← All diseases
Liver, kidneys and digestion
Liver cirrhosis
Would you like to receive a message when there is new research about Liver cirrhosis? This is possible with an account. Create a free account or log in.
Automatically tracked from PubMed and ClinicalTrials.gov, newest on top. Nothing ever disappears here: what you keep in your favorites remains findable. · RSS feed of this disease · only the strongest evidence
Read in plain language what each study is about? With Premium, one sentence above each publication explains what was studied — and you'll be notified as soon as new research on Liver cirrhosis is available. View what Premium costs.
Publications (2524)
- Jiawei Taohe Chengqi decoction alleviates angiogenesis associated with LECT2/CD209-mediated macrophage reprogramming in hepatic fibrosis. (2026/07/29) ♡
- Development of a liver cirrhosis-specific nutrition-focused physical examination tool: A modified Delphi study. (2026/07/29) ♡
- Handgrip strength and diameter-product-derived psoas area estimate in end-stage liver cirrhosis: an exploratory single-center analysis. (2026/07/29) ♡
- Prognostic significance of prior alcohol use disorder in patients with presumed metabolic dysfunction-associated steatotic liver disease: A large multi-center cohort study. (2026/07/29) ♡
- High incidence of advanced liver disease and mortality in patients presenting with alcohol use disorder. (2026/07/29) ♡
- The Association of Dietary Macronutrient Quality and Mortality Among Patients With Liver Cirrhosis: A Prospective Cohort Study. (2026/07/29) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Advances in Precise Assessment of Portal Pressure in Porto-sinusoidal Vascular Disease. (2026/07/28) ♡
- Evaluation of the Safety and Efficacy of SOF/VEL Treatment and Pre-treatment of TAF in Patients with Chronic Hepatitis B Virus/Hepatitis C Virus Coinfection: A Multicenter Study. (2026/07/28) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. The Role of Nitric Oxide in Chronic Liver Disease: A Review. (2026/07/28) ♡
- Baseline Liver Fibrosis Severity Predicts Superior HBeAg Clearance and Fibrosis Reversal following Peg-IFNα plus Nucleos(t)ide Analog Therapy in HBeAg-positive Chronic Hepatitis B Patients. (2026/07/28) ♡
- Disentangling the hepatic risks of familial Mediterranean Fever and colchicine: A propensity score-matched analysis of 19,231 patients. (2026/07/28) ♡
- Sarcopenia in decompensated cirrhosis: a comparative analysis of bioelectrical impedance-based measures. (2026/07/28) ♡
- Protocol for OPAL: Online prehabilitation for patients with cirrhosis awaiting liver transplantation - A multicentre randomized controlled trial. (2026/07/28) ♡
- Machine learning prediction of complications after surgery in cirrhotic patients: Integrating nutritional risk with liver function. (2026/07/27) ♡
- A hepatic enigma: Pediatric presentation of primary biliary cholangitis. (2026/07/27) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Global multicenter validation of noninvasive fibrosis assessment pathways in MetALD and ALD. (2026/07/27) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Oncological and perioperative outcomes in minimally invasive hepatobiliary surgery: A review for the ESSO core curriculum. (2026/07/25) ♡
- Obacunone attenuates Cholestatic liver disease via PPARα activation and gut microbiota remodeling. (2026/07/25) ♡
- Comparative Outcomes of Rifaximin Monotherapy and Lactulose in Cirrhosis: A Multicenter Cohort Study. (2026/07/24) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Fibrosis regression in chronic liver disease: the pathologist's view. (2026/07/24) ♡
- Prospective validation of imaging and serum diagnostic biomarkers of steatohepatitis and fibrosis in MASLD: the LITMUS Imaging Study. (2026/07/24) ♡
- Inflammation-metabolism composite (CRP-triglyceride-glucose index) predicts all-cause and cardiovascular mortality in MASLD with advanced fibrosis: Evidence from a national NHANES cohort. (2026/07/24) ♡
- Bupleuri radix total saikosaponins alleviate liver fibrosis by inhibiting hepatic stellate cell activation via SIRT3-SMAD3/HIF-1α -mediated glycolysis. (2026/07/24) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Exercise and cold exposure as dual physiological stressors in MASLD: AMPK-mediated metabolic adaptation and interorgan crosstalk. (2026/07/24) ♡
- Rural-Urban Disparities in Heart Failure and Liver Cirrhosis Hospitalizations: A National Inpatient Sample Database Analysis (2016-2022). (2026/07/24) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. The new era of MASH pharmacotherapy: a comprehensive review of FDA-approved and emerging agents. (2026/07/23) ♡
- Systematic reviewiAll research on one question is searched according to fixed rules and compared side by side, so that no studies with poor outcomes are missed. Hepatic granulomas as a manifestation of ANCA-associated vasculitis: a systematic review. (2026/07/23) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Supra-hepatic gallbladder in cirrhosis presenting as a mimic of intra-abdominal fat necrosis: Diagnostic pitfalls and clinical implications. (2026/07/23) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Beyond cardiovascular protection: a conceptual and translational review of the hepato-specific mechanisms of statins in metabolic dysfunction-associated steatotic liver disease (MASLD). (2026/07/23) ♡
- A Simplified non-invasive model based on albumin, bilirubin, and platelet count for predicting high-risk varices in compensated cirrhosis. (2026/07/23) ♡
- Plasma metabolic signatures of healthy dietary patterns and risk of metabolic dysfunction-associated steatotic liver disease and cirrhosis. (2026/07/22) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Prior decompensation Identifies Patients at High Mortality Risk Despite Standard Therapy After Variceal Hemorrhage: An IPD Meta-analysis. (2026/07/22) ♡
- AI digital pathology as a key tool providing in-depth understanding of the progression and regression of MASH and fibrosis in male mouse models. (2026/07/22) ♡
- Systematic reviewiAll research on one question is searched according to fixed rules and compared side by side, so that no studies with poor outcomes are missed. Circulating Adipokines in Alcohol-Related Liver Disease and MetALD: A Systematic Review and Structured Narrative Synthesis. (2026/07/22) ♡
- Multimodal OCT Biomarkers of Fibrosis and Steatosis in the Regenerating Liver. (2026/07/22) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Microbiota in cholestatic diseases: crosstalk among bile composition, the biliary microbiome, and host immunity. (2026/07/22) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. ALPPS for perihilar cholangiocarcinoma in a patient with cirrhosis and cardiopulmonary comorbidities: a case report. (2026/07/21) ♡
- Obesity phenotypes, omics signatures, and risk of adverse liver outcomes. (2026/07/21) ♡
- [APASL clinical practice guidelines on the management of chronic hepatitis B infection: a 2026 update]. (2026/07/20) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. The value of mNGS in the diagnosis of central nervous system infections in immunodeficient hosts with decompensated cirrhosis complicated by Listeria encephalitis: Case Report. (2026/07/20) ♡
- CCL20-CCR6 axis mediates mucosal-associated invariant T-M2 macrophage crosstalk to drive immune dysregulation in liver cirrhosis. (2026/07/20) ♡
- Systematic reviewiAll research on one question is searched according to fixed rules and compared side by side, so that no studies with poor outcomes are missed. The efficacy of traditional Chinese medicine on immune function in patients with hepatitis B-related liver fibrosis or cirrhosis: a systematic review and meta-analysis. (2026/07/20) ♡
- Lasso Regression-based Model for Cross-Sectional Identification of Significant Hepatic Fibrosis in NAFLD LASSO-based identification of hepatic fibrosis in NAFLD. (2026/07/20) ♡
- Associations between Heavy Metals and Metalloids and Hepatic Fibrosis Risk in Chinese Adults: A Potential Modifying Effect of Thyroid Hormones. (2026/07/20) ♡
- Laboratory or animal researchiNo research in humans yet. Promising in a test tube or in mice unfortunately means nothing for patients. Evaluating the Hepatoprotective Effect of Phyllanthus emblica and Panax ginseng Powders on Acetaminophen-Induced Liver Fibrosis in a Rat Model. (2026/07/19) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Pharmacological treatment of MASH. (2026/07/17) ♡
- Chronotype and FibroScan-Derived Liver Markers in Adults with Obesity: Preliminary Evidence from a Cross-Sectional Study. (2026/07/16) ♡
- The effects of a diet based on vegetable and dairy protein on nutritional status and MELD score in patients with liver cirrhosis: a randomized controlled study. (2026/07/15) ♡
- Vitamin D supplementation is associated with reduced risk of hepatobiliary malignancy in patients with primary sclerosing cholangitis. (2026/07/15) ♡
- Circulating multi-omic signature of disease severity and cholangiocarcinoma in primary sclerosing cholangitis. (2026/07/15) ♡
codex.care does not provide medical advice. Always discuss symptoms, medication, and treatment choices with your own healthcare provider.